Spots Global Cancer Trial Database for recurrence tumor
Every month we try and update this database with for recurrence tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Usefulness of the Artery First Approach in Pancreatic Cancer Surgery | NCT04136522 | Pancreatic Canc... Margin, Tumor-F... Surgery Site Fi... Recurrence Tumo... | conventional pa... total mesopancr... | 20 Years - | Asan Medical Center | |
| HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular Carcinoma | NCT04499833 | Hepatocellular ... Recurrence Tumo... | liver transplan... | 18 Years - 70 Years | Centro Hospitalar de Lisboa Central | |
| Hepatocarcinoma Recurrence on the Liver Study - Part2 | NCT04053231 | Liver Cancer Surgery Recurrence Tumo... Cirrhosis | liver resection | 18 Years - | University of Milano Bicocca | |
| Usefulness of the Artery First Approach in Pancreatic Cancer Surgery | NCT04136522 | Pancreatic Canc... Margin, Tumor-F... Surgery Site Fi... Recurrence Tumo... | conventional pa... total mesopancr... | 20 Years - | Asan Medical Center | |
| Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma | NCT03457389 | Pituitary Adeno... Prolactinoma Pituitary Tumor Recurrence Tumo... | Cabergoline | 19 Years - | Seoul National University Hospital | |
| Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma | NCT03457389 | Pituitary Adeno... Prolactinoma Pituitary Tumor Recurrence Tumo... | Cabergoline | 19 Years - | Seoul National University Hospital | |
| Bladder Perforation Post-TURBT: Definition, Incidence and Natural HistoryStudy | NCT04129606 | Bladder Cancer Bladder Urothel... Trauma Injuries Perforation of ... Recurrence Tumo... Resection Margi... Seeding, Neopla... | Computed tomogr... | 18 Years - | Mansoura University | |
| Immunotherapy for the Treatment of Advanced Solid Tumor | NCT03658785 | Recurrence Tumo... Metastatic Canc... Solid Tumor | TIL Aldesleukin Cyclophosphamid... Fludarabine | 18 Years - 70 Years | Tongji Hospital | |
| HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular Carcinoma | NCT04499833 | Hepatocellular ... Recurrence Tumo... | liver transplan... | 18 Years - 70 Years | Centro Hospitalar de Lisboa Central | |
| Analgesia aNd caNcer recUrrence Lung cAncer Resection | NCT04656769 | Recurrence Tumo... Opioid Use, Uns... Analgesia Thoracic Surger... | Peridural analg... | 18 Years - | University of Turin, Italy | |
| Usefulness of the Artery First Approach in Pancreatic Cancer Surgery | NCT04136522 | Pancreatic Canc... Margin, Tumor-F... Surgery Site Fi... Recurrence Tumo... | conventional pa... total mesopancr... | 20 Years - | Asan Medical Center | |
| Bladder Perforation Post-TURBT: Definition, Incidence and Natural HistoryStudy | NCT04129606 | Bladder Cancer Bladder Urothel... Trauma Injuries Perforation of ... Recurrence Tumo... Resection Margi... Seeding, Neopla... | Computed tomogr... | 18 Years - | Mansoura University | |
| Analgesia aNd caNcer recUrrence Lung cAncer Resection | NCT04656769 | Recurrence Tumo... Opioid Use, Uns... Analgesia Thoracic Surger... | Peridural analg... | 18 Years - | University of Turin, Italy | |
| Moderate Whole Body Hyperthermia for Patients Undergoing Re-irradiation for Head and Neck Cancer -Influence on the Tumor Microenvironment | NCT03547388 | Head and Neck N... Recurrence Tumo... | Moderate whole ... | 18 Years - 75 Years | Charite University, Berlin, Germany | |
| Combi-elastography Assessment of HCC Recurrence After Thermal Ablation Multi-center Study | NCT04640363 | HCC Recurrence Tumo... | 18 Years - 80 Years | Chinese PLA General Hospital | ||
| Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas | NCT03423992 | Glioma Malignant Gliom... Recurrence Tumo... | chimeric antige... | 18 Years - 70 Years | Xuanwu Hospital, Beijing |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
